Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study

被引：0

作者：

Lei Huang

Yesilda Balavarca

Lydia van der Geest

Valery Lemmens

Liesbet Van Eycken

Harlinde De Schutter

Tom B. Johannesen

Vesna Zadnik

Maja Primic-Žakelj

Margit Mägi

Robert Grützmann

Marc G. Besselink

Petra Schrotz-King

Hermann Brenner

Lina Jansen

机构：

[1] German Cancer Research Center (DKFZ),Division of Clinical Epidemiology and Aging Research

[2] Heidelberg University,Medical Faculty Heidelberg

[3] German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT),Division of Preventive Oncology

[4] Netherlands Comprehensive Cancer Organization (IKNL),Netherlands Cancer Registry (NCR)

[5] Belgian Cancer Registry (BCR),Registry Department

[6] The Cancer Registry of Norway (CRN),Epidemiology and Cancer Registry

[7] Institute of Oncology Ljubljana,Estonian Cancer Registry

[8] National Institute for Health Development,Department of Surgery

[9] Friedrich-Alexander-University Erlangen-Nürnberg,Dutch Pancreatic Cancer Group (DPCG), Department of Surgery, Cancer Center Amsterdam

[10] Amsterdam University Medical Centers (UMC),undefined

[11] Academic Medical Center (AMC),undefined

[12] University of Amsterdam,undefined

[13] German Cancer Consortium (DKTK),undefined

[14] German Cancer Research Center (DKFZ),undefined

来源：

BMC Medicine | / 17卷

关键词：

Pancreatic cancer; Resection; Chemotherapy; Survival; Prognostic factors; Benchmark population-based nomogram; International real-world cohort study;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 352 条

[1]

Torre LA(2015)Global cancer statistics, 2012 CA Cancer J Clin 65 87-108

[2]

Bray F(2019)Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations Gut 68 130-139

[3]

Siegel RL(2018)Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study BMC Med 16 125-1061

[4]

Ferlay J(2017)Pancreatic adenocarcinoma, version 2.2017, NCCN Clinical Practice Guidelines in Oncology J Natl Compr Cancer Netw 15 1028-2556

[5]

Lortet-Tieulent J(2016)Potentially curable pancreatic cancer: American Society of Clinical Oncology Clinical Practice Guideline J Clin Oncol 34 2541-v68

[6]

Jemal A(2015)Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 26 v56-3239

[7]

Huang L(2018)Non-surgical therapies for resected and unresected pancreatic cancer in Europe and USA in 2003-2014: a large international population-based study Int J Cancer 143 3227-132

[8]

Jansen L(2008)Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature JOP 9 99-115

[9]

Balavarca Y(2018)Impact of tumor size on survival of patients with resected pancreatic ductal adenocarcinoma: a systematic review and meta-analysis BMC Cancer 18 985-463

[10]

Molina-Montes E(2017)The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma - a systematic review and meta-analysis Surg Oncol 26 105-268

← 1 2 3 4 5 6 7 8 9 10 →